lg 100268 and dactinomycin

lg 100268 has been researched along with dactinomycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goto, K; Mu, YM; Nawata, H; Nishi, Y; Takayanagi, R; Yanase, T	1

Other Studies

1 other study(ies) available for lg 100268 and dactinomycin

Article	Year
Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells. Molecular and cellular endocrinology, 2001, Jul-05, Volume: 181, Issue:1-2 Topics: Aromatase; Cell Division; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Estrone; Female; Granulosa Cell Tumor; Humans; Ligands; Nicotinic Acids; Ovary; Promoter Regions, Genetic; Radioimmunoassay; Receptors, Cytoplasmic and Nuclear; Receptors, FSH; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured	2001

Article

Year

Combined treatment with specific ligands for PPARgamma:RXR nuclear receptor system markedly inhibits the expression of cytochrome P450arom in human granulosa cancer cells.

Molecular and cellular endocrinology, 2001, Jul-05, Volume: 181, Issue:1-2

Topics: Aromatase; Cell Division; Chromans; Dactinomycin; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Estrone; Female; Granulosa Cell Tumor; Humans; Ligands; Nicotinic Acids; Ovary; Promoter Regions, Genetic; Radioimmunoassay; Receptors, Cytoplasmic and Nuclear; Receptors, FSH; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcription, Genetic; Troglitazone; Tumor Cells, Cultured

2001